Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2012
07/04/2012CN102153647B Anti-EGFR (epidemic growth factor receptor) humanized antibody L3-H3 and coding gene and application thereof
07/04/2012CN102080066B Method for detecting T-2 toxin and special reagent kit thereof
07/04/2012CN101955956B Eimeria tenella calcium-dependent protein kinase gene and application thereof
07/04/2012CN101955545B Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori
07/04/2012CN101914153B Pb2+ antigen and corresponding monoclonal antibody and preparation method thereof
07/04/2012CN101875695B Antibody, and coding gene and application thereof
07/04/2012CN101812132B Humanized neutralizing antibody (RVFab3) against rabies virus glycoprotein
07/04/2012CN101812131B Humanized neutralizing antibody (RVFab8) against rabies virus glycoprotein
07/04/2012CN101812130B Humanized neutralizing antibody (RVFab5) against rabies virus glycoprotein
07/04/2012CN101798349B Anti-uPAR humanized antibody and coding gene thereof
07/04/2012CN101759804B Anti-human thyroglobulin monoclonal antibody and application thereof
07/04/2012CN101652476B Anti-FGF23 antibody and pharmaceutical composition comprising the same
07/04/2012CN101591392B Enterovirus 71 type intravenous human immunoglobulin and preparation method thereof
07/04/2012CN101575593B Vaccine for hand-foot-mouth disease and preparation method and application thereof
07/04/2012CN101497909B Method for preparing anti-A type botulinus toxin immunoglobulin antibody
07/04/2012CN101497662B TM4SF3 protein for preparing antineoplastic antibody and use thereof
07/04/2012CN101412756B Method for detecting chlorothalonil pesticide residue and detection kit therefor
07/04/2012CN101360760B Biological materials and uses thereof
07/04/2012CN101321870B Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
07/04/2012CN101230096B Peptide derived from hepatitis C virus
07/04/2012CN101189265B Anti-il2 antibodies
07/04/2012CN101161675B Rice big grain gene and uses thereof
07/04/2012CN101072794B Method for affinity purification
07/03/2012US8212010 Sphingosine 1-phosphate antagonism
07/03/2012US8212009 Methods and compounds for lymphoma cell detection and isolation
07/03/2012US8212008 Antibodies to CD200R
07/03/2012US8212004 Hybridoma cell for use in propagation of immunoglobulins for treatment and prevention of autoimmune, pancreatic, blood and cell proliferative disorders
07/03/2012US8212002 Synthesis of glatiramer acetate
07/03/2012US8211658 Complex of a chaperone with β-amyloid and methods employing this complex
07/03/2012US8211649 Methods of diagnosing and prognosing hodgkin's lymphoma
07/03/2012US8211648 Secretion of antibodies without signal peptides from bacteria
07/03/2012US8211434 KLK-13 antibody inhibitor for treating dry eye
07/03/2012US8211432 Treatment of Staphylococcus aureus infections utilizing antibodies that bind to fibronectin binding proteins
07/03/2012US8211422 Comprising a first gene segment encoding a single-chain Fv domain (scFv) of a specific antibody and a second gene segment encoding partially or entirely the transmembrane and cytoplasmic domains; gene therapy; antitumor agents
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2446968C Human artificial chromosome containing human antibody .lambda. light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2402593C Monoclonal antibodies to the human ldl receptor, their production and use
07/03/2012CA2397610C In vivo assay for testing the phenotypic stability
07/03/2012CA2350227C Novel serine protease bssp5
07/03/2012CA2330618C Viral chimeras comprised of caev and hiv-1 genetic elements
07/03/2012CA2318052C Antibodies against human il-12
07/03/2012CA2315294C Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
07/03/2012CA2296737C Ligand for herpes simplex virus entry mediator and methods of use
07/02/2012CA2806314A1 Method for purifying active polypeptides or immunoconjugates
06/2012
06/28/2012WO2012088313A1 Anti-pcsk9 antibodies and methods of use
06/28/2012WO2012088290A2 Tri-variable domain binding proteins and uses thereof
06/28/2012WO2012088006A1 Fibronectin based scaffold domain proteins that bind il-23
06/28/2012WO2012087962A2 Anti-mesothelin antibodies and immunoconjugates
06/28/2012WO2012087437A2 Bin1 expression as a marker of skeletal muscle mass and neurological conditions
06/28/2012WO2012086750A1 Antibody
06/28/2012WO2012086660A1 Support for affinity chromatography and method for isolating immunoglobulin
06/28/2012WO2012085872A2 Stable immunogenic compositions of staphylococcus aureus antigens
06/28/2012WO2012085447A1 Method for assaying antibodies directed against factor viii
06/28/2012WO2012085132A1 Antibodies against human cd39 and use thereof
06/28/2012WO2012085113A1 Binding agent
06/28/2012WO2012085111A1 Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
06/28/2012WO2012085069A2 Detection of a polypeptide dimer by a bivalent binding agent
06/28/2012WO2012085015A1 Anti-il-18 antibodies and their uses
06/28/2012WO2012084829A1 Isoform enriched antibody preparation and method for obtaining it
06/28/2012WO2012084272A1 Oprf/i agents and their use in hospitalized and other patients
06/28/2012WO2012083837A1 Porcine circovirus type 2, immune composition containing the same, assay kit, and use thereof
06/28/2012WO2012083475A1 Neutralizing polyclonal antibody against hantavirusandes, production method and pharmaceutical compositions
06/28/2012WO2012083425A1 Novel alkali-resistant variants of protein a and their use in affinity chromatography
06/28/2012WO2012083370A1 Modified antibody with improved half-life
06/28/2012WO2012061811A3 Anti- connective tissue growth factor agent for use in the treatment of lung remodeling disease
06/28/2012WO2012059873A3 Anti-diabetic compounds
06/28/2012WO2012058768A8 Stable heterodimeric antibody design with mutations in the fc domain
06/28/2012WO2012053828A9 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
06/28/2012WO2012051282A3 Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy
06/28/2012WO2012010946A3 Bnip3 isoforms and methods of use
06/28/2012WO2011146568A8 Predicting response to a her inhibitor
06/28/2012US20120167237 Animal models and therapeutic molecules
06/28/2012US20120165646 Composite particle, contrast agent for photoacoustic imaging, and photoacoustic imaging method
06/28/2012US20120165512 Antigen Binding Fragments of an Antibody for Use in Treating or Diagnosing Ocular Diseases
06/28/2012US20120165511 Protein purification using hcic and ion exchange chromatography
06/28/2012US20120165398 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
06/28/2012US20120165340 Pten phosphorylation-driven resistance to cancer treatment and altered patient prognosis
06/28/2012US20120165250 Active Cores of Peptide Triazole HIV-1 Entry Inhibitors
06/28/2012US20120165226 Phage display
06/28/2012US20120165218 Method and assay for determining fas expression
06/28/2012US20120165211 Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques
06/28/2012US20120164756 Aspirin assay
06/28/2012US20120164685 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
06/28/2012US20120164673 Ptp1b inhibitors
06/28/2012US20120164667 Method for test on diabetic nephropathy
06/28/2012US20120164664 T1r taste receptors and genes encoding same
06/28/2012US20120164662 Test method on renal diseases
06/28/2012US20120164660 Method for using a diagnostic agent which includes a calcium binding protein assay reagent and assay method for calcium binding protein
06/28/2012US20120164659 Human hcv-interacting proteins and methods of use
06/28/2012US20120164629 Antibodies For Oncogenic Strains Of HPV And Methods Of Their Use
06/28/2012US20120164230 Soluble Nanoparticles as Delivery Systems for Prodrugs
06/28/2012US20120164170 Porcine Circovirus Type 2 (PCV2), Immunogenic Composition Containing the Same, Test Kit, and Application Thereof
06/28/2012US20120164169 Bovine herpesvirus vaccine
06/28/2012US20120164167 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof
06/28/2012US20120164166 Neisseria meningitidis antigens and compositions
06/28/2012US20120164163 Cdc45l peptides and vaccines including the same
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164160 Monoclonal antibodies against claudin-18 for treatment of cancer
1 ... 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 ... 1494